Crescent Biopharma, Inc. (CBIO) KPIs and segments
CBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 10/30
$14.37−0.39 (-2.61%)
Close on Nov 12, 2026Market cap $533.76MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Crescent Biopharma's business
Coming soon
This tab will track the numbers specific to Crescent Biopharma's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?